腫瘍内微小環境の能動的制御に基づくsiRNAデリバリー技術の開発とがん治療への展開

DOI Web Site Web Site PubMed 参考文献30件
  • 石田 竜弘
    徳島大学大学院ヘルスバイオサイエンス研究部薬物動態学分野
  • 際田 弘志
    徳島大学大学院ヘルスバイオサイエンス研究部薬物動態学分野

書誌事項

タイトル別名
  • Development of siRNA Delivery Strategy by Active Control of Tumor Microenvironment
  • シュヨウ ナイ ビショウ カンキョウ ノ ノウドウテキ セイギョ ニ モトズク siRNA デリバリー ギジュツ ノ カイハツ ト ガン チリョウ エ ノ テンカイ

この論文をさがす

説明

  Efficient systemic siRNA delivery to cells in the target tissue is a current critical challenge in the drug delivery field. Several studies have demonstrated that nanoparticles such as polyethylene glycol (PEG)-coated siRNA-lipoplexes may enhance the systemic delivery of siRNA to tumor. However, the disordered tumor microenvironment still poses a potential impediment with respect to the efficient delivery of PEG-coated siRNA-lipoplexes. We recently showed that metronomic S-1 dosing (daily oral administration) enhanced the accumulation of PEG-coated liposome containing anticancer drug in solid tumor tissue and thereby increased therapeutic efficacy in tumor-bearing mouse model. To extend this work, we tried to investigate the effect of metronomic S-1 dosing on the intratumoral accumulation of PEG-coated siRNA-lipoplex and, thereby, their therapeutic efficacy in solid tumor-bearing mouse model. Results showed that metronomic S-1 dosing improved systemic delivery of intravenously injected PEG-coated siRNA-lipoplexes into solid tumor tissue. In addition, the combined therapy of S-1 and PEG-coated siRNA-lipoplexes showed potent tumor growth suppressive effect. Our proposed strategy may pose a promising therapeutic one to conquer cancer progression with siRNA.<br>

収録刊行物

  • 薬学雑誌

    薬学雑誌 133 (3), 379-386, 2013-03-01

    公益社団法人 日本薬学会

参考文献 (30)*注記

もっと見る

関連プロジェクト

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ